The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Allan Jonathan since 2023.
This trader's CIK number is 1966716.
At the time of last reporting, Allan Jonathan was the GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc.. (stock ticker symbol STOK).
Also see all insider trading activities at Stoke Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | STOK | 0 | $0 | 41,723 | $716,922 | 29,475 | $70,699 |
| 2024 | STOK | 0 | $0 | 30,837 | $389,720 | 13,475 | $0 |
| 2023 | STOK | 0 | $0 | 5,844 | $78,759 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-03 | STOK | Sale | 6,345 | 20.07 | 127,318 |
| 2025-08-29 | STOK | Option Ex | 850 | 7.07 | 6,009 |
| 2025-09-02 | STOK | Option Ex | 9,150 | 7.07 | 64,690 |
| 2025-08-29 | STOK | Sale | 850 | 20.00 | 17,000 |
| 2025-09-02 | STOK | Sale | 14,922 | 20.14 | 300,499 |
| 2025-08-18 | STOK | Sale | 1,683 | 18.24 | 30,694 |
| 2025-08-14 | STOK | Option Ex | 6,000 | .00 | 0 |
| 2025-08-13 | STOK | Sale | 13,712 | 15.00 | 205,680 |
| 2025-03-18 | STOK | Sale | 2,266 | 8.67 | 19,646 |
| 2025-03-19 | STOK | Sale | 1,945 | 8.27 | 16,085 |
| 2025-03-15 | STOK | Option Ex | 13,475 | .00 | 0 |
| 2024-12-09 | STOK | Sale | 13,666 | 13.34 | 182,304 |
| 2024-12-06 | STOK | Sale | 9,696 | 12.78 | 123,895 |
| 2024-12-03 | STOK | Option Ex | 6,000 | .00 | 0 |
| 2024-03-28 | STOK | Sale | 5,126 | 13.50 | 69,195 |
| 2024-03-19 | STOK | Sale | 2,349 | 6.10 | 14,326 |
| 2024-03-15 | STOK | Option Ex | 7,475 | .00 | 0 |
| 2023-06-21 | STOK | Sale | 1,948 | 13.48 | 26,253 |
| 2023-06-21 | STOK | Sale | 1,948 | 13.48 | 26,253 |
| 2023-06-21 | STOK | Sale | 1,948 | 13.48 | 26,253 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Allan Jonathan (GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.